Swedish Orphan Biovitrum AB (B6E) Q1 2026 Earnings Report
DE:B6E Q1 2026 EPS Results
- Actual EPS
- EUR 0.35
- Consensus EPS
- EUR 0.33
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- EUR 0.23
DE:B6E Q1 2026 Revenue Results
- Actual Revenue
- EUR 653.23M
- Expected Revenue
- EUR 648.04M
- Beat/Miss
- Beat by +EUR 5.19M
- YoY Revenue Growth
- +11.12%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/28/2026
- Time
- Before Open
- Conference Call
- Tuesday, April 28, 2026
DE:B6E Upcoming Earnings
Swedish Orphan Biovitrum AB's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B6E Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 0.60- | 0.49 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 0.550.61 | -0.76 | 180.41% (+1.36) | |
| Jul 16, 2026 | 2026 (Q2) | 0.310.29 | 0.17 | 71.58% (+0.12) | |
| Apr 28, 2026 | 2026 (Q1) | 0.330.35 | 0.23 | 49.41% (+0.11) | |
| Feb 05, 2026 | 2025 (Q4) | 0.380.49 | 0.37 | 32.43% (+0.12) | |
| Oct 20, 2025 | 2025 (Q3) | 0.42-0.76 | 0.39 | -294.85% (-1.14) | |
| Jul 16, 2025 | 2025 (Q2) | 0.150.17 | 0.06 | 177.27% (+0.11) | |
| Apr 29, 2025 | 2025 (Q1) | 0.200.23 | 0.21 | 8.51% (+0.02) | |
| Feb 05, 2025 | 2024 (Q4) | 0.330.37 | 0.27 | 34.77% (+0.10) | |
| Oct 24, 2024 | 2024 (Q3) | 0.200.39 | 0.05 | 690.74% (+0.34) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
